AI Engines For more Details: Perplexity Kagi Labs You
Reduction of Intraocular Pressure (IOP): Dorzolamide is a carbonic anhydrase inhibitor that works by decreasing the production of aqueous humor in the eye, thereby lowering intraocular pressure. It is typically used as an adjunctive therapy when monotherapy with beta-blockers or prostaglandin analogs is insufficient to control IOP.
Treatment of Open-Angle Glaucoma: Open-angle glaucoma is a chronic eye condition characterized by increased fluid pressure within the eye, which can damage the optic nerve and lead to vision loss. Dorzolamide, either alone or in combination with other anti-glaucoma medications, is used to manage this condition and prevent further optic nerve damage.
Management of Ocular Hypertension: Ocular hypertension refers to elevated intraocular pressure without signs of optic nerve damage or visual field loss characteristic of glaucoma. Dorzolamide can be prescribed to lower IOP in individuals with ocular hypertension to reduce the risk of developing glaucoma.
Adjunctive Therapy: Dorzolamide is often prescribed in combination with other intraocular pressure-lowering medications, such as beta-blockers (e.g., timolol) or prostaglandin analogs (e.g., latanoprost), to achieve optimal IOP control. Combination therapy may offer additive or synergistic effects in reducing IOP.
Improved Ocular Blood Flow: Some studies suggest that dorzolamide may have vasodilatory effects on ocular blood vessels, potentially improving ocular perfusion and blood flow to the retina and optic nerve head. This may contribute to its neuroprotective properties in glaucoma management.
Decreased Risk of Visual Field Loss: By effectively lowering intraocular pressure, dorzolamide helps reduce the risk of progressive visual field loss and deterioration of visual function associated with glaucoma. Early initiation and consistent use of dorzolamide therapy may help preserve vision in affected individuals.
Enhanced Outflow Facility: Dorzolamide may enhance aqueous outflow through the trabecular meshwork, facilitating the drainage of intraocular fluid from the eye. This mechanism of action contributes to its ability to reduce intraocular pressure and improve ocular hemodynamics.
Adjunctive Therapy in Pediatric Glaucoma: Dorzolamide can be used as adjunctive therapy in children and adolescents with pediatric glaucoma to lower intraocular pressure and prevent optic nerve damage. It is often administered in combination with other topical anti-glaucoma medications.
Rank | Probiotic | Impact |
---|---|---|
genus | Bifidobacterium | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Bifidobacterium longum | Reduces |
species | Blautia hansenii | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Faecalibacterium prausnitzii | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
species | Streptococcus thermophilus | Reduces |
subspecies | Bifidobacterium longum subsp. infantis | Reduces |
subspecies | Bifidobacterium longum subsp. longum | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Roseburia | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Streptococcus | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Butyrivibrio | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Subdoligranulum | genus | Decreases |
0 | 1 | Wansuia | genus | Decreases |
0 | 1 | Pseudobutyrivibrio | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Wujia | genus | Decreases |
0 | 1 | Ligilactobacillus | genus | Decreases |
0 | 1 | Anaerobutyricum | genus | Decreases |
0 | 1 | Massilistercora | genus | Decreases |
0 | 1 | Komagataeibacter | genus | Decreases |
0 | 1 | Simiaoa | genus | Decreases |
0 | 1 | Intestinibaculum | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Eubacterium | genus | Decreases |
0 | 1 | Catenibacterium | genus | Decreases |
0 | 1 | Dorea | genus | Decreases |
0 | 1 | Qiania | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Christensenella | genus | Decreases |
0 | 1 | Treponema | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Novisyntrophococcus | genus | Decreases |
0 | 1 | Lachnoanaerobaculum | genus | Decreases |
0 | 1 | Maliibacterium | genus | Decreases |
0 | 1 | Faecalitalea | genus | Decreases |
0 | 1 | Faecalibacterium | genus | Decreases |
0 | 1 | Faecalibacillus | genus | Decreases |
0 | 1 | Marvinbryantia | genus | Decreases |
0 | 1 | Adlercreutzia | genus | Decreases |
0 | 1 | Chordicoccus | genus | Decreases |
0 | 1 | Oscillibacter | genus | Decreases |
0 | 1 | Vescimonas | genus | Decreases |
0 | 1 | Collinsella | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 1 | Bifidobacterium | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
1 | 0 | Bacteroides xylanisolvens | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
1 | 0 | Roseburia intestinalis | species | Decreases |
1 | 0 | Streptococcus parasanguinis | species | Decreases |
1 | 0 | Streptococcus salivarius | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
0 | 1 | Streptococcus sp. FDAARGOS_192 | species | Decreases |
0 | 1 | Streptococcus sp. LPB0220 | species | Decreases |
0 | 1 | Streptococcus sp. HSISM1 | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Blautia argi | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
0 | 1 | Bacteroides sp. DH3716P | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Blautia obeum | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Streptococcus vestibularis | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Streptococcus gordonii | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Bacteroides luhongzhouii | species | Decreases |
0 | 1 | Streptococcus lactarius | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Lachnospira eligens | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Streptococcus australis | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 061 | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Streptococcus infantis | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Streptococcus oralis | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Blautia hansenii | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Alistipes sp. dk3624 | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Bacteroides faecium | species | Decreases |
0 | 1 | Streptococcus sp. oral taxon 431 | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Blautia parvula | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Lawsonibacter asaccharolyticus | species | Decreases |
0 | 1 | Blautia pseudococcoides | species | Decreases |
0 | 1 | Streptococcus sp. Marseille-Q6470 | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Phascolarctobacterium sp. Marseille-Q4147 | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Collinsella aerofaciens | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Blautia producta | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Streptococcus ilei | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Thomasclavelia ramosa | species | Decreases |
0 | 1 | Pusillibacter faecalis | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Flintibacter sp. KGMB00164 | species | Decreases |
0 | 1 | Faecalibacterium prausnitzii | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Alistipes communis | species | Decreases |
0 | 1 | [Clostridium] scindens | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
0 | 1 | Intestinimonas butyriciproducens | species | Decreases |
0 | 1 | Bacteroides caecimuris | species | Decreases |
0 | 1 | Enterocloster bolteae | species | Decreases |
0 | 1 | Anaerostipes caccae | species | Decreases |
0 | 1 | Romboutsia sp. 13368 | species | Decreases |
0 | 1 | Alistipes indistinctus | species | Decreases |
0 | 1 | Streptococcus sp. A12 | species | Decreases |
0 | 1 | Streptococcus sanguinis | species | Decreases |
0 | 1 | Streptococcus thermophilus | species | Decreases |
0 | 1 | Streptococcus cristatus | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
1 | 0 | Bifidobacterium longum | species | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. infantis | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. longum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suillum | subspecies | Decreases |
0 | 1 | Bifidobacterium longum subsp. suis | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.5 | 0.5 | |
Acne | 0 | 0 | |
ADHD | 1.7 | 1.1 | 0.55 |
Age-Related Macular Degeneration and Glaucoma | 0.8 | 0 | 0 |
Allergic Rhinitis (Hay Fever) | 2 | 2 | 0 |
Allergies | 3.3 | 1.4 | 1.36 |
Allergy to milk products | 1.8 | 0.9 | 1 |
Alopecia (Hair Loss) | 0.4 | 0.2 | 1 |
Alzheimer's disease | 4.3 | 6.1 | -0.42 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.1 | 0.9 | 1.33 |
Ankylosing spondylitis | 2.6 | 1.5 | 0.73 |
Anorexia Nervosa | 0.6 | 2.7 | -3.5 |
Antiphospholipid syndrome (APS) | 1.5 | 0.4 | 2.75 |
Asthma | 3.5 | 1.6 | 1.19 |
Atherosclerosis | 2.4 | 1.3 | 0.85 |
Atrial fibrillation | 2.5 | 2.5 | 0 |
Autism | 5.3 | 6.3 | -0.19 |
Autoimmune Disease | 0.9 | 0.6 | 0.5 |
Barrett esophagus cancer | 0.2 | 0.4 | -1 |
benign prostatic hyperplasia | 0.5 | 0.4 | 0.25 |
Biofilm | 2.7 | 2.7 | |
Bipolar Disorder | 1.7 | 1 | 0.7 |
Brain Trauma | 0.7 | 1.2 | -0.71 |
Breast Cancer | 1 | 1 | |
Cancer (General) | 0.2 | 0.9 | -3.5 |
Carcinoma | 3.3 | 1.4 | 1.36 |
Celiac Disease | 3 | 1.4 | 1.14 |
Cerebral Palsy | 0.8 | 1 | -0.25 |
Chronic Fatigue Syndrome | 3.4 | 5.1 | -0.5 |
Chronic Kidney Disease | 2.3 | 3 | -0.3 |
Chronic Lyme | 0.8 | -0.8 | |
Chronic Obstructive Pulmonary Disease (COPD) | 3 | 1.8 | 0.67 |
Chronic Urticaria (Hives) | 1.2 | 1.1 | 0.09 |
Coagulation / Micro clot triggering bacteria | 1.6 | 1.6 | 0 |
Cognitive Function | 1.5 | 1.2 | 0.25 |
Colorectal Cancer | 6.8 | 2.2 | 2.09 |
Constipation | 1.4 | 0.6 | 1.33 |
Coronary artery disease | 3 | 3.2 | -0.07 |
COVID-19 | 4.3 | 8.4 | -0.95 |
Crohn's Disease | 7.2 | 4.6 | 0.57 |
Cushing's Syndrome (hypercortisolism) | 0.7 | -0.7 | |
cystic fibrosis | 0.8 | 0.9 | -0.13 |
d-lactic acidosis (one form of brain fog) | 0.6 | 0.6 | |
deep vein thrombosis | 2.5 | 1.9 | 0.32 |
Denture Wearers Oral Shifts | 1.6 | 1.6 | |
Depression | 7.3 | 6.6 | 0.11 |
Dermatomyositis | 0.4 | 0 | 0 |
Eczema | 1.9 | 1.7 | 0.12 |
Endometriosis | 2.6 | 1.6 | 0.63 |
Eosinophilic Esophagitis | 0.2 | 0.4 | -1 |
Epilepsy | 3.2 | 0.6 | 4.33 |
erectile dysfunction | 1.1 | 0 | 0 |
Fibromyalgia | 1 | 1.6 | -0.6 |
Functional constipation / chronic idiopathic constipation | 4.5 | 2.7 | 0.67 |
gallstone disease (gsd) | 2.6 | 0.9 | 1.89 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 1.8 | 1.3 | 0.38 |
Generalized anxiety disorder | 2.9 | 1.3 | 1.23 |
Glioblastoma | 0.1 | 0.5 | -4 |
Gout | 1.4 | 0.5 | 1.8 |
Graves' disease | 0.5 | 1.7 | -2.4 |
Gulf War Syndrome | 0.8 | 0.6 | 0.33 |
Halitosis | 1.6 | 0.4 | 3 |
Hashimoto's thyroiditis | 2.4 | 1.5 | 0.6 |
Heart Failure | 4.1 | 2.1 | 0.95 |
hemorrhagic stroke | 0.5 | 0.5 | |
Hidradenitis Suppurativa | 1.5 | 1.5 | |
High Histamine/low DAO | 1 | 0.3 | 2.33 |
hypercholesterolemia (High Cholesterol) | 0.6 | 0.2 | 2 |
hyperglycemia | 2 | 0.5 | 3 |
Hyperlipidemia (High Blood Fats) | 0.7 | 0.2 | 2.5 |
hypersomnia | 0.5 | -0.5 | |
hypertension (High Blood Pressure | 2.3 | 3.9 | -0.7 |
Hypothyroidism | 0.2 | 0.8 | -3 |
Hypoxia | 0.6 | 0.6 | |
IgA nephropathy (IgAN) | 1.2 | 1.9 | -0.58 |
Inflammatory Bowel Disease | 6.4 | 7.3 | -0.14 |
Insomnia | 2.2 | 1.9 | 0.16 |
Intelligence | 1.4 | 0.8 | 0.75 |
Intracranial aneurysms | 0.7 | 0.7 | 0 |
Irritable Bowel Syndrome | 4.4 | 3 | 0.47 |
ischemic stroke | 1.5 | 1.7 | -0.13 |
Juvenile idiopathic arthritis | 0.1 | -0.1 | |
Liver Cirrhosis | 5.8 | 3.7 | 0.57 |
Long COVID | 4.7 | 4.7 | 0 |
Low bone mineral density | 1.5 | -1.5 | |
Lung Cancer | 0.9 | 0.6 | 0.5 |
Lymphoma | 0.5 | 0.5 | |
Mast Cell Issues / mastitis | 1.3 | 0.5 | 1.6 |
ME/CFS with IBS | 0.6 | 2.4 | -3 |
ME/CFS without IBS | 1.4 | 1 | 0.4 |
membranous nephropathy | 0.4 | 0.4 | |
Menopause | 0.7 | 0.7 | 0 |
Metabolic Syndrome | 6.7 | 5.2 | 0.29 |
Mood Disorders | 6.5 | 5 | 0.3 |
multiple chemical sensitivity [MCS] | 1.1 | 0.1 | 10 |
Multiple Sclerosis | 3.7 | 4.2 | -0.14 |
Multiple system atrophy (MSA) | 0.8 | 0.1 | 7 |
myasthenia gravis | 1 | 0.7 | 0.43 |
neuropathic pain | 1.2 | -1.2 | |
Neuropathy (all types) | 0.5 | 0.9 | -0.8 |
neuropsychiatric disorders (PANDAS, PANS) | 0.9 | 0.1 | 8 |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 3.7 | 3.2 | 0.16 |
NonCeliac Gluten Sensitivity | 0.4 | 0.4 | 0 |
Obesity | 7 | 6.7 | 0.04 |
obsessive-compulsive disorder | 3.6 | 2.8 | 0.29 |
Osteoarthritis | 2.3 | 1.4 | 0.64 |
Osteoporosis | 1.4 | 1.1 | 0.27 |
pancreatic cancer | 0.8 | 0.4 | 1 |
Parkinson's Disease | 6.1 | 6.7 | -0.1 |
Polycystic ovary syndrome | 4.6 | 1.8 | 1.56 |
Postural orthostatic tachycardia syndrome | 0.4 | -0.4 | |
Premenstrual dysphoric disorder | 0.1 | 0 | 0 |
primary biliary cholangitis | 0.7 | 0.9 | -0.29 |
Primary sclerosing cholangitis | 1.7 | 2.1 | -0.24 |
Psoriasis | 2.2 | 2.3 | -0.05 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 5.5 | 3.3 | 0.67 |
Rosacea | 0.3 | 0.6 | -1 |
Schizophrenia | 2.9 | 1.8 | 0.61 |
scoliosis | 1.3 | 0.7 | 0.86 |
sensorineural hearing loss | 0.4 | 0.4 | |
Sjögren syndrome | 1.5 | 1.3 | 0.15 |
Sleep Apnea | 1.4 | 1.2 | 0.17 |
Slow gastric motility / Gastroparesis | 1.1 | 0 | 0 |
Small Intestinal Bacterial Overgrowth (SIBO) | 2.2 | 0 | 0 |
Stress / posttraumatic stress disorder | 2 | 1.5 | 0.33 |
Systemic Lupus Erythematosus | 3.6 | 1.2 | 2 |
Tic Disorder | 1 | 1 | 0 |
Tourette syndrome | 0.5 | 0.3 | 0.67 |
Type 1 Diabetes | 3.3 | 2.4 | 0.38 |
Type 2 Diabetes | 7.4 | 5.2 | 0.42 |
Ulcerative colitis | 5 | 4.4 | 0.14 |
Unhealthy Ageing | 4.2 | 1.9 | 1.21 |
Vitiligo | 1.8 | 0.8 | 1.25 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]